Sven Arke Lang
- Surgery top 2%
- Hepatology top 0.5%
- Oncology top 2%
- Epidemiology top 5%
- Molecular Biology
- Co-authors
- Hans J. SchlittMartin LossEdward K. GeisslerStefan Fichtner‐FeiglUlf P. NeumannAlfred KönigsrainerAlexander KroemerAndreas A. Schnitzbauer
- Topics
- Cholangiocarcinoma and Gallbladder Cancer Studies (36 papers)Hepatocellular Carcinoma Treatment and Prognosis (31 papers)Pancreatic and Hepatic Oncology Research (26 papers)
- Cited by
- HepatologyOncologySurgery
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaPLoS ONE
- Partner nations
- GermanyNetherlandsUnited Kingdom
In The Last Decade
Sven Arke Lang
107 papers receiving 2.9k citations
Hit Papers
Peers
Comparison fields: 5 of 102
- Surgery 1.4k
- Hepatology 1.2k
- Oncology 1.2k
- Epidemiology 586
- Molecular Biology 469
Countries citing papers authored by Sven Arke Lang
This map shows the geographic impact of Sven Arke Lang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sven Arke Lang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sven Arke Lang more than expected).
Fields of papers citing papers by Sven Arke Lang
This network shows the impact of papers produced by Sven Arke Lang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sven Arke Lang. The network helps show where Sven Arke Lang may publish in the future.
Co-authorship network of co-authors of Sven Arke Lang
This figure shows the co-authorship network connecting the top 25 collaborators of Sven Arke Lang. A scholar is included among the top collaborators of Sven Arke Lang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sven Arke Lang. Sven Arke Lang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 9 | |
| 5 | 15 | |
| 6 | 7 | |
| 7 | 6 | |
| 8 | 9 | |
| 9 | 5 | |
| 10 | 4 | |
| 11 | 24 | |
| 12 | 3 | |
| 13 | 22 | |
| 14 | 6 | |
| 15 | 76 | |
| 16 | 7 | |
| 17 | 16 | |
| 18 | 35 | |
| 19 | 110 | |
| 20 | 46 |
About Sven Arke Lang
Sven Arke Lang is a scholar working on Hepatology, Oncology and Transplantation, having authored 112 papers that have together received 2.9k indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (36 papers), Hepatocellular Carcinoma Treatment and Prognosis (31 papers) and Pancreatic and Hepatic Oncology Research (26 papers). The work is most often cited by research in Hepatology (1.2k citations), Oncology (1.2k citations) and Surgery (1.4k citations). Sven Arke Lang has collaborated with scholars based in Germany, Netherlands and United Kingdom. Frequent co-authors include Hans J. Schlitt, Martin Loss, Edward K. Geissler, Stefan Fichtner‐Feigl, Ulf P. Neumann, Alfred Königsrainer, Alexander Kroemer, Andreas A. Schnitzbauer, Marcus N. Scherer and Aiman Obed. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.